(Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 18.25%-786.35K | -48.47%-2.51M | -662.78%-2.14M | -606.83%-4.53M | -10,848.29%-1.9M | -1,267.61%-961.91K | -1,704.32%-1.69M | 39.90%-280.21K | 46.53%-641.08K | 103.96%17.72K |
Net income from continuing operations | -3.95%-2.1M | -111.87%-1.53M | -923.05%-3.38M | -368.74%-5.18M | -1,957.57%-2.3M | -1,286.77%-2.02M | -161.41%-723.27K | 21.64%-330.09K | -89.15%-1.11M | 79.64%-111.68K |
Depreciation and amortization | 428.62%321.37K | 2,753.62%357.5K | 647.41%160.74K | 99.51%200.29K | 8,283.76%88.71K | 79.29%60.79K | -139.85%-13.47K | --21.51K | 2.69%100.39K | -107.45%-1.08K |
Asset impairment expenditure | 1,029.97%609.15K | --5.3K | --26.87K | --103.99K | --50.08K | --53.91K | ---- | --0 | --0 | --0 |
Remuneration paid in stock | -73.60%157.17K | ---21.84K | --1.09M | --260.16K | ---133.42K | --595.42K | ---- | --0 | --0 | --0 |
Other non cashItems | --0 | ---1.32M | --1 | 70.95%-5.49K | ---- | ---- | ---- | ---- | -409.28%-18.9K | ---- |
Change In working capital | -35.65%220.98K | 100.22%2.06K | -238.11%-39.19K | -75.76%92.9K | 163.47%393.57K | 735.76%343.43K | -858.84%-950.62K | 163.07%28.37K | 274.58%383.2K | -68.26%149.38K |
-Change in receivables | ---- | ---212.81K | 16.75%-109.07K | -61.82%-12.89K | 590.74%308.11K | -582.50%-94.92K | ---- | ---131.01K | 65.96%-7.97K | ---62.79K |
-Change in inventory | ---- | ---1.94K | --3.11K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
-Change in prepaid assets | ---- | --12.59K | 687.34%29.97K | -2,575.54%-115.91K | -1,256.55%-29.92K | --58.91K | ---- | ---5.1K | 151.05%4.68K | --2.59K |
-Change in payables and accrued expense | ---- | --258.51K | -150.67%-145.14K | 194.76%412.85K | 194.92%152.04K | 2,970.27%355.97K | ---- | --286.44K | 182.83%140.06K | --51.55K |
-Change in other working capital | ---- | ---54.28K | 249.20%181.95K | -177.58%-191.16K | -123.20%-36.66K | 138.91%23.47K | ---- | ---121.95K | 953.84%246.42K | --158.02K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 18.25%-786.35K | -48.47%-2.51M | -662.78%-2.14M | -606.83%-4.53M | -10,848.29%-1.9M | -1,267.61%-961.91K | -1,704.34%-1.69M | 39.90%-280.21K | 46.53%-641.08K | 103.96%17.72K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,418.65%-579.49K | -15,755.54%-7.97M | 849.25%586.72K | -1,140.31%-193.68K | -178.84%-17.08K | -397.56%-38.16K | -627.32%-50.24K | 619.10%61.81K | 125.97%18.62K | 168.26%21.67K |
Net PPE purchase and sale | ---3.28K | 66.82%-4.28K | 19.41%-8.68K | -845.97%-45.56K | -354.61%-21.89K | --0 | ---12.88K | ---10.77K | 65.39%-4.82K | ---4.82K |
Net intangibles purchas and sale | 4,510,700.00%45.11K | 1,709.75%37.97K | -3,331.72%-83.08K | ---- | ---- | 100.01%1 | 65.85%-2.36K | 79.67%-2.42K | ---- | ---- |
Net business purchase and sale | -1,528.23%-621.32K | -22,757.14%-8M | 804.64%678.48K | ---148.13K | --33 | ---38.16K | ---35K | --75K | --0 | --0 |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | --1 | ---- | 231.47%23.43K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,418.65%-579.49K | -15,755.86%-7.97M | 849.25%586.72K | -1,140.31%-193.68K | -178.84%-17.08K | -397.56%-38.16K | -627.30%-50.24K | 619.10%61.81K | 125.97%18.62K | 168.26%21.67K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -18.06%140.57K | 4,964.53%10.03M | -91.92%380.3K | 1,648.69%7.37M | 956.38%2.45M | 71.55%171.55K | 120.03%198.02K | 4.71M | -76.03%421.66K | -70.09%231.66K |
Net issuance payments of debt | 47,712.59%140.57K | ---13.98K | ---11.94K | -155.70%-169.68K | -248.26%-169.98K | -99.71%294 | --0 | --0 | 850.54%304.65K | 174.24%114.65K |
Net common stock issuance | --0 | 1,588.38%10.01M | --0 | 1,962.97%3.4M | --597.03K | ---2.19M | --592.7K | --5M | -91.15%165.02K | ---- |
Proceeds from stock option exercised by employees | --0 | --0 | --654.13K | --4.14M | --1.72M | --2.42M | ---- | --0 | --0 | ---- |
Net other financing activities | --0 | 109.10%35.92K | 9.92%-261.88K | ---- | ---- | ---57.67K | ---394.68K | ---290.73K | 26.20%-48K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -18.06%140.57K | 4,964.53%10.03M | -91.92%380.3K | 1,648.69%7.37M | 956.38%2.45M | 71.55%171.55K | 120.03%198.02K | --4.71M | -76.03%421.66K | -70.09%231.66K |
Net cash flow | ||||||||||
Beginning cash position | -52.75%1.54M | -61.33%1.85M | 879.65%2.95M | -40.01%301.09K | 7,968.47%2.42M | 40,327.23%3.25M | 17,835.31%4.79M | -40.01%301.09K | 3,732.08%501.89K | -85.49%30.04K |
Current changes in cash | -47.89%-1.23M | 71.26%-442.51K | -126.06%-1.17M | 1,418.99%2.65M | 93.97%525.76K | -3,866.69%-828.52K | -14,668.19%-1.54M | 1,039.22%4.49M | -141.08%-200.8K | -8.09%271.05K |
Effect of exchange rate changes | --39.54K | --126.21K | --73.94K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
End cash Position | -85.51%351.14K | -52.75%1.54M | -61.33%1.85M | 879.65%2.95M | 879.65%2.95M | 7,968.47%2.42M | 19,861.77%3.25M | 20,088.55%4.79M | -40.01%301.09K | -40.01%301.09K |
Free cash from | 23.50%-744.52K | -45.16%-2.47M | -659.76%-2.23M | -608.61%-4.58M | -12,146.25%-1.92M | -1,147.61%-973.19K | -1,595.40%-1.7M | 38.64%-293.4K | 48.44%-645.9K | 103.45%15.95K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data